SCHEMBL7876518

SCHEMBL7876518

C[C@H](N(O)C=O)[C@](C)(C(=O)O)C1CCCc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.42
MAPK14 Q16539 1/20 0.42
ALDH1A1 P00352 3/20 0.40
HTT P42858 2/20 0.40
XBP1 P17861 1/20 0.40
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.36
TSHR P16473 2/20 0.36
BLM P54132 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CAMK2A Q9UQM7 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876520 0.73 ALDH1A1 (0.42) ALDH1A1HTTXBP1RAB9ATSHR
SCHEMBL14815564 0.68 IDO1 (0.46) MAPK1MAPK14ALDH1A1HTTXBP1
SCHEMBL20706323 0.68 IDO1 (0.49) MAPK1MAPK14ALDH1A1HTTXBP1
SCHEMBL10786599 0.67 IDO1 (0.40) MAPK1MAPK14ALDH1A1HTTRAB9A
SCHEMBL9515277 0.66 IDO1 (0.44) MAPK1MAPK14ALDH1A1HTTXBP1
SCHEMBL22808450 0.66 IDO1 (0.50) MAPK1MAPK14ALDH1A1HTTXBP1
SCHEMBL9004030 0.65 IDO1 (0.49) ALDH1A1HTTLMNATSHRBLM
SCHEMBL5951346 0.65 TSHR (0.47) ALDH1A1HTTXBP1TSHRBLM
SCHEMBL3394130 0.64 PDPK1 (0.44) MAPK1MAPK14ALDH1A1HTTRAB9A
SCHEMBL30276343 0.64 HTT (0.51) ALDH1A1HTTLMNATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed